title: Skin necrosis after injection of PEG-interferon alpha2b in an HCV-infected patient.
authors.forename: Agnés
authors.initials: A
authors.lastname: Sparsa
authors.forename: Véronique
authors.initials: V
authors.lastname: Loustaud-Ratti
authors.forename: Sophie
authors.initials: S
authors.lastname: Alain
authors.forename: Eric
authors.initials: E
authors.lastname: Liozon
authors.forename: Christophe
authors.initials: C
authors.lastname: Bédane
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Vidal
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000473:pathology / Q000821:virology*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b